Canada markets closed

Oncolytics Biotech Inc. (ONCY)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.0200-0.0100 (-0.97%)
At close: 04:00PM EDT
1.0600 +0.04 (+3.92%)
After hours: 07:36PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 76.82M
Enterprise Value 56.11M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)4.60
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.40
52-Week Change 3-46.60%
S&P500 52-Week Change 323.76%
52 Week High 33.3900
52 Week Low 30.8800
50-Day Moving Average 31.1026
200-Day Moving Average 31.3750

Share Statistics

Avg Vol (3 month) 3217.31k
Avg Vol (10 day) 3200.08k
Shares Outstanding 575.42M
Implied Shares Outstanding 677.18M
Float 872.62M
% Held by Insiders 13.90%
% Held by Institutions 11.92%
Shares Short (May 15, 2024) 4866.07k
Short Ratio (May 15, 2024) 44.34
Short % of Float (May 15, 2024) 41.22%
Short % of Shares Outstanding (May 15, 2024) 41.15%
Shares Short (prior month Apr 15, 2024) 4928.07k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3May 25, 2018
Ex-Dividend Date 4N/A
Last Split Factor 210:95
Last Split Date 3May 25, 2018

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-63.83%
Return on Equity (ttm)-115.80%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -35.7M
Net Income Avi to Common (ttm)-28.21M
Diluted EPS (ttm)-0.2900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)29.6M
Total Cash Per Share (mrq)0.39
Total Debt (mrq)1.13M
Total Debt/Equity (mrq)4.91%
Current Ratio (mrq)8.14
Book Value Per Share (mrq)0.31

Cash Flow Statement

Operating Cash Flow (ttm)-28.09M
Levered Free Cash Flow (ttm)-17.2M